by CheckRare Staff and Ailene Cantelmi | Oct 12, 2026
Jorge Nieva, MD, Associate Professor at the Keck School of Medicine, discusses new analyses from the TRUST studies evaluating taletrectinib in patients with ROS1-positive non-small cell lung cancer (NSCLC). ROS1-positive NSCLC is a rare molecular subtype of...
by Madaline Spencer and Ailene Cantelmi | Oct 5, 2026
Paz Vellanki, MD, PhD, Vice President of Clinical Development at Precision for Medicine, discusses the FDA CDER’s Accelerating Rare Disease Cures (ARC) Program. The ARC Program was launched in 2022 with the goal of accelerating the development of safe and...
by Madaline Spencer and Ailene Cantelmi | Sep 30, 2026
A study published in The Lancet evaluated the safety and efficacy of ralinepag in patients with pulmonary arterial hypertension (PAH). PAH is a rare condition affecting the heart and lungs, characterized by abnormally high blood pressure (hypertension) in the...
